首页|治疗前HALP评分和NLR对食管癌放化疗患者预后的预测价值

治疗前HALP评分和NLR对食管癌放化疗患者预后的预测价值

扫码查看
目的 探讨食管癌放化疗患者治疗前的血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分和中性粒细胞/淋巴细胞比值(NLR)及两者的预后预测价值.方法 选取 2019 年 1 月至 2020 年 12 月于本院肿瘤内科行食管癌放化疗的106 例患者作为研究对象,依据疗效评价分为预后良好组(n=55)和预后不良组(n=51).收集两组患者的临床资料并分析HALP评分和NLR与食管癌患者临床病理特征的关系,采用Kaplan-Meier法进行生存分析,Pearson相关分析HALP 评分和NLR与食管癌患者放化疗后并发症的相关性,受试者工作特征(ROC)曲线分析 HALP 评分、NLR和鳞状上皮细胞癌抗原(SCC)对食管癌患者预后的预测价值.结果 与预后不良组比较,预后良好组食管癌患者的HALP 评分增加,而NLR减少(P<0.05);HALP评分、NLR与食管癌患者的 TNM 分期、分化程度、淋巴结转移等不良预后病理特征密切相关(P<0.05).HALP评分与食管癌患者的营养不良、放射性食管炎、肺部感染呈负相关(r=-0.614、-0.437、-0.541,P<0.001);NLR与患者的肺部感染、放射性食管炎呈正相关(r=0.469、0.410,P<0.001).HALP评分、NLR与SCC联合检测预测食管癌预后的曲线下面积为0.883(95%CI:0.806~0.937),最大约登指数为 0.8120,敏感度为 0.8889,特异度为 0.9231.结论 HALP评分、NLR是食管癌预后评估有价值的生物标记物,可为临床医护人员制定食管癌不良预后策略提供参考依据.
Predictive value of HALP score and NLR before treatment for the prognosis of esophageal cancer patients undergoing radiotherapy and chemotherapy
Objective To explore the prognostic value of hemoglobin,albumin,lymphocyte,and platelet(HALP)scores and neutrophil-to-lymphocyte ratio(NLR)in patients with esophageal cancer undergoing radiotherapy and chemotherapy before treatment.Methods One hundred and six patients with esophageal cancer who underwent radiotherapy and chemotherapy in the Department of Oncology at our hospital from January 2019 to December 2021 were selected as the study subjects.According to the efficacy evaluation,they were divided into a good prognosis group(n=55)and a poor prognosis group(n=51).Clinical data of two groups were collected,and relationships of HALP score and NLR with the clinical pathological characteristics of esophageal cancer patients were analyzed.Kaplan-Meier method was used for survival analysis,and Pearson correlation analysis was used to investigate the correlation of HALP score and NLR with postoperative complications of esophageal cancer patients after radiotherapy and chemotherapy.Receiver operating characteristic(ROC)curve analysis was used to evaluate the prognostic value of HALP score,NLR,and squamous cell carcinoma antigen(SCC)in esophageal cancer patients.Results Compared with the poor prognosis group,the HALP score of esophageal cancer patients in the good prognosis group increased,while the NLR decreased(P<0.05).The HALP score and NLR were closely related to adverse prognostic pathological features such as TNM staging,tissue differentiation degree,and lymph node metastasis in esophageal cancer patients(P<0.05).The HALP score was negatively correlated with malnutrition,radiation-induced esophagitis,and pulmonary infection in patients with esophageal cancer(r=-0.614,-0.437,-0.541,P<0.001).The NLR was positively correlated with pulmonary infection and radiation-induced esophagitis in patients(r=0.469,0.410,P<0.001).Combined detection of HALP score,NLR,and SCC predicted the area under the prognosis curve of esophageal cancer to be 0.883(95%CI:0.806-0.937),with a maximum Jordan index of 0.8120,sensitivity of 0.8889 and specificity of 0.9231.Conclusion The HALP and NLR scoring systems are valuable biomarkers for prognostic evaluation of esophageal cancer,and can provide reference for clinical healthcare professionals to develop adverse prognostic strategies for esophageal cancer.

Esophageal cancerHemoglobin,albumin,lymphocyte and platelet(HALP)scoresNeutrophil lymphocyte ratio(NLR)Prognosis

任秀芹、秦素萍、吴贤翠、俞颖

展开 >

210006 南京 南京医科大学附属南京医院/南京市第一医院南院门诊

210006 南京医科大学附属南京医院/南京市第一医院肿瘤内科

食管癌 血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分 中性粒细胞-淋巴细胞比值(NLR) 预后

2024

临床肿瘤学杂志
解放军第八一医院

临床肿瘤学杂志

CSTPCD
影响因子:1.583
ISSN:1009-0460
年,卷(期):2024.29(7)